- SYRE Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Spyre Therapeutics (SYRE) 8-K12 Apr 23Results from Cohorts 1 and 2 Showed a Dose-Dependent Reduction in Total Homocysteine LevelsFinancial data
Company Profile